At the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans this month, Marilyn Telen, MD, professor of medicine, presented new research that uncovers several important insights into the pathophysiology of sickle cell disease and thalassemia that may soon translate into the development of better, more targeted treatments for hundreds of thousands of patients worldwide.
Dr. Telen's presentation was GMI-1070: Reduction in Time to Resolution of Vaso-Occlusive Crisis and Decreased Opioid Use in a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease (GMI-1070-201)
Read more here and here.